# WOMAN-2 primary results, Lancet 2024

Publication · id `maternal:pub-woman-2-lancet-2024` · Maternal & Newborn Atlas · release `fc5a600ec7387e71` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Browse, life stage: Childbirth; Postpartum  
Browse, care area: Recovery after birth  

## In plain language

The main report of the WOMAN-2 trial of tranexamic acid to prevent bleeding after birth in women with anaemia, published in The Lancet in 2024.

## Technical summary

Lancet 2024;404(10463):1645-1656. doi:10.1016/S0140-6736(24)01749-5. PMID 39461792.

## Connected pages

- Published in: The Lancet (`core:lancet`)

## Provenance

Content hash: ca6ee1867c07141a6378a262bf0cf304f1db7df51562f2779c3aa040f648fe8c
Last substantive edit: 2026-10-15
Evidence last checked: Not recorded